Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,594
Closed -$262K 992
2021
Q4
$262K Sell
1,594
-148,806
-99% -$23.9M ﹤0.01% 941
2021
Q3
$22.4M Buy
150,400
+14,282
+10% +$2.97M 0.03% 262
2021
Q2
$33.3M Buy
136,118
+97,255
+250% +$25.5M 0.05% 210
2021
Q1
$10.3M Buy
38,863
+31,174
+405% +$8.79M 0.02% 329
2020
Q4
$2.22M Sell
7,689
-2,038
-21% -$523K ﹤0.01% 537
2020
Q3
$2.3M Sell
9,727
-771
-7% -$175K 0.01% 467
2020
Q2
$2.08M Buy
+10,498
New +$1.96M 0.01% 466

Other funds holding AMED

DZ Bank's AMED Position: Q1 2022 in Review

DZ Bank sold out of Amedisys (AMED) in Q1 2022, closing a stake of 1,594 shares — an estimated $262K sold.

DZ Bank first reported a position in AMED in Q2 2020 and held it in 7 quarters. The position peaked at $33.3M in Q2 2021. 328 funds tracked by Wall St. Rank hold AMED as of Q1 2022.

  • DZ Bank reported no remaining Amedisys position as of Q1 2022 after selling out during the quarter.
  • DZ Bank sold 1,594 Amedisys shares in Q1 2022, an estimated $262K.
  • DZ Bank first reported a position in Amedisys in Q2 2020 and held it in 7 quarters.
  • DZ Bank's Amedisys position peaked at $33.3M in Q2 2021.
  • 328 funds tracked by Wall St. Rank held Amedisys as of Q1 2022.

Based on DZ Bank's 13F filing for Q1 2022, filed 16 May 2022.